Philips wins FDA nod for AI-powered, detector-based spectral CT tech

Philips (NYSE:PHG) announced today that it received FDA 510(k) clearance for its AI-powered Spectral CT Verida system.

The company touts Verida as the world’s first detector-based spectral CT fully powered by AI. Amsterdam-based Philips unveiled the technology in December 2025.

Philips designed Verida to transform CT imaging, using AI to optimize the entire imaging chain. The company says it lowers system noise, elevates image quality and accelerates the clinical workflow.

Sign up for Blog Updates